Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.11 USD | +0.91% | -0.89% | -16.54% |
05-13 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
05-09 | Transcript : Co-Diagnostics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.54% | 34.39M | |
-18.82% | 18.18B | |
-43.96% | 2.84B | |
+23.49% | 1.94B | |
-3.70% | 1.64B | |
+31.41% | 1.33B | |
-16.85% | 953M | |
-23.12% | 891M | |
+3.17% | 865M | |
+24.76% | 543M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Earnings Flash (CODX) CO-DIAGNOSTICS Posts Q2 Revenue $0.2M